Summit Therapeu ADR (SMMT)
18.19 -0.01 (-0.05%) 01/16/25 [NASDAQ]
18.21 x 100 18.29 x 300
Realtime by (Cboe BZX)
18.21 x 100 18.29 x 300
Realtime 18.29 +0.10 (+0.55%) 17:19 ET
for Thu, Jan 16th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Cash Flows From Operating Activities | |||||
Net Income | -614,928 | -78,782 | -88,602 | -52,697 | -29,127 |
Depreciation Amortization | 2,050 | 2,514 | 2,455 | 2,003 | 1,638 |
Accounts receivable | 359 | 975 | -1,138 | 212 | 5,439 |
Accounts payable and accrued liabilities | 2,263 | -4,132 | -1,711 | 1,642 | -1,306 |
Other Working Capital | -6,536 | 179 | 5,948 | 5,000 | 2,009 |
Other Operating Activity | 540,032 | 37,664 | 10,461 | -4,271 | 590 |
Operating Cash Flow | $-76,760 | $-41,582 | $-72,587 | $-48,111 | $-20,757 |
Cash Flows From Investing Activities | |||||
Change In Deposits | -112,857 | N/A | N/A | N/A | N/A |
PPE Investments | 98 | -624 | -306 | -421 | -205 |
Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -136 |
Other Investing Activity | -475,015 | 0 | 0 | 0 | -136 |
Investing Cash Flow | $-587,774 | $-624 | $-306 | $-421 | $-341 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | N/A | 545,000 | 110,000 | N/A | N/A |
Common Stock Issued | 111,818 | 100,399 | 78,088 | 50,599 | 50,417 |
Other Financing Activity | -25,305 | -25,155 | -110,172 | -48 | -912 |
Financing Cash Flow | $86,513 | $620,244 | $77,916 | $50,551 | $49,505 |
Exchange Rate Effect | 839 | -1,222 | 351 | 556 | 190 |
Beginning Cash Position | 648,607 | 71,791 | 66,417 | 63,842 | 35,245 |
End Cash Position | 71,425 | 648,607 | 71,791 | 66,417 | 63,842 |
Net Cash Flow | $-577,182 | $576,816 | $5,374 | $2,575 | $28,597 |
Free Cash Flow | |||||
Operating Cash Flow | -76,760 | -41,582 | -72,587 | -48,111 | -20,757 |
Capital Expenditure | -128 | -624 | -306 | -421 | -205 |
Free Cash Flow | -76,888 | -42,206 | -72,893 | -48,532 | -20,962 |